Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
:BCLI
RESEARCH TOOLSreports
Brainstorm Cell Therapeutics (BCLI) Ownership Overview
20.15% Insiders
2.23% Mutual Funds
2.66% Other Institutional Investors
0.86% ETFs
74.10% Public Companies and
Individual Investors
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 5.75% of the company’s stock is owned by Institutional Investors, 20.15% is owned by Insiders, and 74.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 02, 2024 | Chaim Lebovits President & Ceo | xxxxxxxxxxxxx | $11119 |
| Jul 24, 2024 | xxxxxxxxxxxxx | $22050 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,060,000 | Insider | 6.25% | 4,865,400 | |
| 334,349 | Insider | 5.86% | 531,615 | |
| 79,515 | Insider | 1.39% | 126,429 | |
| 77,451 | Institution | 1.36% | 123,147 | |
| 68,464 | Insider | 1.20% | 108,858 | |
| 52,000 | Insider | 0.91% | 82,680 | |
| 48,869 | Institution | 0.86% | 77,702 | |
| 48,229 | Insider | 0.85% | 76,684 | |
| 46,320 | Institution | 0.81% | 73,649 | |
| 44,349 | Insider | 0.78% | 70,515 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 77,451 | Institution | 1.36% | 123,147 | |
| 46,320 | Institution | 0.81% | 73,649 | |
| 3,152 | Institution | 0.06% | 5,012 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,734 | Institution | 0.47% | 43,576 |
FAQ
Who Owns Brainstorm Cell Therapeutics (BCLI)?
According to the latest TipRanks data, approximately 2.66% of the company's stock is held by institutional investors, 20.15% is held by insiders, and 74.10% is held by retail investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.66% of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors.
What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.10% of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors.
Who owns the most shares of Brainstorm Cell Therapeutics (BCLI)?
Ness Kevin Dean owns the most shares of Brainstorm Cell Therapeutics (BCLI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.